Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antibiotic DTC Ads Will Stress Proper Use To Reduce Resistance

Executive Summary

FDA is urging companies proposing direct-to-consumer advertising campaigns for antibiotics to incorporate an educational message into the ads promoting cautious use of the drugs.

You may also be interested in...



Antimicrobial Advertising Guidance Should Target Resistance - FDA Group

An FDA guidance on direct-to-consumer advertising of antimicrobials should address resistance issues, an agency-wide task force report suggests.

Antimicrobial Advertising Guidance Should Target Resistance - FDA Group

An FDA guidance on direct-to-consumer advertising of antimicrobials should address resistance issues, an agency-wide task force report suggests.

FDA Considering Exclusivity Program As Antimicrobial Development Incentive

A drug exclusivity program is being considered by FDA as an incentive to encourage investment in antimicrobial product development, FDA Commissioner Henney, MD, indicated during a Senate Appropriations/Labor, HHS & Education subcommittee hearing Sept. 20.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS033555

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel